183 related articles for article (PubMed ID: 30138538)
1. 27-Hydroxycholesterol, an Endogenous SERM, and Risk of Fracture in Postmenopausal Women: A Nested Case-Cohort Study in the Women's Health Initiative.
Chang PY; Feldman D; Stefanick ML; McDonnell DP; Thompson BM; McDonald JG; Lee JS
J Bone Miner Res; 2019 Jan; 34(1):59-66. PubMed ID: 30138538
[TBL] [Abstract][Full Text] [Related]
2. Sex Steroid Hormones and Fracture in a Multiethnic Cohort of Women: The Women's Health Initiative Study (WHI).
Cauley JA; Danielson ME; Jammy GR; Bauer DC; Jackson R; Wactawski-Wende J; Chlebowski RT; Ensrud KE; Boudreau R
J Clin Endocrinol Metab; 2017 May; 102(5):1538-1547. PubMed ID: 28324031
[TBL] [Abstract][Full Text] [Related]
3. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial.
Cauley JA; Robbins J; Chen Z; Cummings SR; Jackson RD; LaCroix AZ; LeBoff M; Lewis CE; McGowan J; Neuner J; Pettinger M; Stefanick ML; Wactawski-Wende J; Watts NB;
JAMA; 2003 Oct; 290(13):1729-38. PubMed ID: 14519707
[TBL] [Abstract][Full Text] [Related]
4. Circulating 27-Hydroxycholesterol and Breast Cancer Risk: Results From the EPIC-Heidelberg Cohort.
Lu DL; Le Cornet C; Sookthai D; Johnson TS; Kaaks R; Fortner RT
J Natl Cancer Inst; 2019 Apr; 111(4):365-371. PubMed ID: 30016454
[TBL] [Abstract][Full Text] [Related]
5. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.
Anderson GL; Limacher M; Assaf AR; Bassford T; Beresford SA; Black H; Bonds D; Brunner R; Brzyski R; Caan B; Chlebowski R; Curb D; Gass M; Hays J; Heiss G; Hendrix S; Howard BV; Hsia J; Hubbell A; Jackson R; Johnson KC; Judd H; Kotchen JM; Kuller L; LaCroix AZ; Lane D; Langer RD; Lasser N; Lewis CE; Manson J; Margolis K; Ockene J; O'Sullivan MJ; Phillips L; Prentice RL; Ritenbaugh C; Robbins J; Rossouw JE; Sarto G; Stefanick ML; Van Horn L; Wactawski-Wende J; Wallace R; Wassertheil-Smoller S;
JAMA; 2004 Apr; 291(14):1701-12. PubMed ID: 15082697
[TBL] [Abstract][Full Text] [Related]
6. The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.
Gurney EP; Nachtigall MJ; Nachtigall LE; Naftolin F
J Steroid Biochem Mol Biol; 2014 Jul; 142():4-11. PubMed ID: 24172877
[TBL] [Abstract][Full Text] [Related]
7. OPG and sRANKL serum levels and incident hip fracture in postmenopausal Caucasian women in the Women's Health Initiative Observational Study.
LaCroix AZ; Jackson RD; Aragaki A; Kooperberg C; Cauley JA; Chen Z; Leboff MS; Duggan D; Wactawski-Wende J
Bone; 2013 Oct; 56(2):474-81. PubMed ID: 23735608
[TBL] [Abstract][Full Text] [Related]
8. Estrogen, vascular estrogen receptor and hormone therapy in postmenopausal vascular disease.
Khalil RA
Biochem Pharmacol; 2013 Dec; 86(12):1627-42. PubMed ID: 24099797
[TBL] [Abstract][Full Text] [Related]
9. Coronary heart disease events in the Women's Health Initiative hormone trials: effect modification by metabolic syndrome: a nested case-control study within the Women's Health Initiative randomized clinical trials.
Wild RA; Wu C; Curb JD; Martin LW; Phillips L; Stefanick M; Trevisan M; Manson JE
Menopause; 2013 Mar; 20(3):254-60. PubMed ID: 23435021
[TBL] [Abstract][Full Text] [Related]
10. Effects of conjugated equine estrogen on risk of fractures and BMD in postmenopausal women with hysterectomy: results from the women's health initiative randomized trial.
Jackson RD; Wactawski-Wende J; LaCroix AZ; Pettinger M; Yood RA; Watts NB; Robbins JA; Lewis CE; Beresford SA; Ko MG; Naughton MJ; Satterfield S; Bassford T;
J Bone Miner Res; 2006 Jun; 21(6):817-28. PubMed ID: 16753012
[TBL] [Abstract][Full Text] [Related]
11. Endogenous hormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group.
Cummings SR; Browner WS; Bauer D; Stone K; Ensrud K; Jamal S; Ettinger B
N Engl J Med; 1998 Sep; 339(11):733-8. PubMed ID: 9731089
[TBL] [Abstract][Full Text] [Related]
12. Associations of serum sex hormone-binding globulin and sex hormone concentrations with hip fracture risk in postmenopausal women.
Lee JS; LaCroix AZ; Wu L; Cauley JA; Jackson RD; Kooperberg C; Leboff MS; Robbins J; Lewis CE; Bauer DC; Cummings SR
J Clin Endocrinol Metab; 2008 May; 93(5):1796-803. PubMed ID: 18334588
[TBL] [Abstract][Full Text] [Related]
13. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
Rapp SR; Espeland MA; Shumaker SA; Henderson VW; Brunner RL; Manson JE; Gass ML; Stefanick ML; Lane DS; Hays J; Johnson KC; Coker LH; Dailey M; Bowen D;
JAMA; 2003 May; 289(20):2663-72. PubMed ID: 12771113
[TBL] [Abstract][Full Text] [Related]
14. A Prospective Evaluation of Endogenous Sex Hormone Levels and Colorectal Cancer Risk in Postmenopausal Women.
Murphy N; Strickler HD; Stanczyk FZ; Xue X; Wassertheil-Smoller S; Rohan TE; Ho GY; Anderson GL; Potter JD; Gunter MJ
J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26232761
[TBL] [Abstract][Full Text] [Related]
15. Women's Health Initiative clinical trials: interaction of calcium and vitamin D with hormone therapy.
Robbins JA; Aragaki A; Crandall CJ; Manson JE; Carbone L; Jackson R; Lewis CE; Johnson KC; Sarto G; Stefanick ML; Wactawski-Wende J
Menopause; 2014 Feb; 21(2):116-23. PubMed ID: 23799356
[TBL] [Abstract][Full Text] [Related]
16. The effects of postmenopausal hormone therapy on serum estrogen, progesterone, and sex hormone-binding globulin levels in healthy postmenopausal women.
Edlefsen KL; Jackson RD; Prentice RL; Janssen I; Rajkovic A; O'Sullivan MJ; Anderson G
Menopause; 2010; 17(3):622-9. PubMed ID: 20215977
[TBL] [Abstract][Full Text] [Related]
17. Baseline serum estradiol and fracture reduction during treatment with hormone therapy: the Women's Health Initiative randomized trial.
Cauley JA; LaCroix AZ; Robbins JA; Larson J; Wallace R; Wactawski-Wende J; Chen Z; Bauer DC; Cummings SR; Jackson R
Osteoporos Int; 2010 Jan; 21(1):167-77. PubMed ID: 19436934
[TBL] [Abstract][Full Text] [Related]
18. Coronary Artery Calcification (CAC) and Post-Trial Cardiovascular Events and Mortality Within the Women's Health Initiative (WHI) Estrogen-Alone Trial.
Poornima IG; Mackey RH; Allison MA; Manson JE; Carr JJ; LaMonte MJ; Chang Y; Kuller LH;
J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29079563
[TBL] [Abstract][Full Text] [Related]
19. [27- Hydroxycholesterol reverses estradiol induced inhibition of platelet aggregation in postmenopausal women].
Rocha G; Sierralta W; Valladares L
Rev Med Chil; 2016 Nov; 144(11):1377-1381. PubMed ID: 28394953
[TBL] [Abstract][Full Text] [Related]
20. The relevance of the Women's Health Initiative results on combined hormone replacement therapy in clinical practice.
Lemay A
J Obstet Gynaecol Can; 2002 Sep; 24(9):711-5. PubMed ID: 12360366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
